360Dx – VALID Act Divides Dx World as IVD Biz Welcomes Consistency, Flexibility While Labs Fear Red Tape
WASHINGTON – During a panel discussion at the Next Generation Dx Summit this week in Washington, D.C., stakeholders from the lab and diagnostics world tackled questions around the Verifying Accurate Leading-edge IVCT Development (VALID) Act and how it could affect those industries. The bill, which would formally give the US Food and Drug Administration authority…